Introduction
Measuring what people habitually eat is a central challenge in understanding the relationship between diet and chronic disease. Nutritional biomarkers offer a way to assess exposure without relying entirely on self-reported intake.
But how much can a measurement in blood or urine actually tell us about someone’s diet? And when might it reflect underlying metabolism or early disease processes?
In this episode, Dr. Fumiaki Imamura explains the strengths and limitations of nutritional biomarkers, drawing on research into fatty acids, Mediterranean dietary patterns, and sodium.
Dr. Imamura is a nutritional epidemiologist and senior scientist at the University of Cambridge, whose work investigates dietary exposures and their relationships with diabetes and cardiovascular disease.
- [03:37] Guest background
- [05:41] What are nutritional biomarkers?
- [07:27] What makes biomarkers robust
- [09:48] Why epidemiology needs biomarkers
- [13:48] Limits and confounders
- [16:24] Dairy fat biomarkers and diabetes
- [22:08] Causality and metabolic effects
- [26:00] Fatty acid patterns and scores
- [31:27] Best use cases sodium example
- [35:07] Combining biomarkers and diet data
- [41:29] Premium key ideas
Episode Resources
- Join the Sigma newsletter for free
- Subscribe to Sigma Nutrition Premium
- Enroll in the next cohort of our Applied Nutrition Literacy course
- Related papers:
- Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes (2018)
- Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes (2020)
- A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study (2017)
- A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes (2023)
Guest Information
Dr. Fumiaki Imamura is a Senior Investigator Scientist in nutritional epidemiology at the University of Cambridge, UK. His research examines relationships between diet and cardiometabolic health, with particular interests in dietary patterns, nutritional biomarkers, and type 2 diabetes. His work includes prospective cohort studies, analyses of circulating fatty acids, and systematic reviews of observational studies and dietary interventions.
He holds a master’s degree in nutrition from Columbia University, and a PhD in nutritional epidemiology from Tufts University. Before joining Cambridge, he completed a postdoctoral fellowship in the Department of Epidemiology at Harvard School of Public Health.
Study Notes
Overview
Nutritional biomarkers provide objective measurements that can strengthen dietary assessment and help investigate diet–disease relationships. Their interpretation depends on what determines the measured value: dietary intake, endogenous metabolism, physiological state, the biological sample, and the period represented by that sample.
Using fatty acids, type 2 diabetes, dietary patterns, and sodium as examples, this episode explores what biomarkers can resolve, what they leave uncertain, and why they work best alongside conventional dietary assessment.
- A more objective measurement can reduce particular reporting errors without establishing that the measured substance causes disease.
- A biomarker may represent nutritional status, dietary exposure, metabolic processes, or a combination of these.
- Combining biomarkers can capture a broader biological profile, while making attribution to individual nutrients more difficult.
- Dietary questionnaires remain important for identifying foods, preparation methods, and feasible intervention targets.
Useful Terminology
- Nutritional biomarker: A measurable characteristic of a biological sample used to provide information about nutrition-related exposure, status, or processes. Its meaning must be established for the intended application.
- Exposure biomarker: A measurement used to indicate exposure to a nutrient, food component, supplement, or contaminant. It need not be a direct quantitative measure of intake.
- Status biomarker: A measurement that informs assessment of nutrient adequacy or deficiency. Exposure and status functions can overlap, as with vitamin C.
- Endogenous synthesis: Production within the body. A circulating nutrient-related molecule may originate partly from synthesis rather than direct dietary intake.
- De novo lipogenesis: Synthesis of fatty acids from non-fat precursors. Fatty acids associated with this pathway can reflect metabolism as well as dietary influences.
- Confounding: Distortion of an exposure–outcome association by other factors related to both. Statistical adjustment depends on what was measured and how accurately it was measured.
- Reverse causation: A developing disease process changes the exposure or biomarker, making the biomarker appear to precede disease causally even when it partly reflects that process.
- Biomarker pattern or score: A weighted combination of measurements used to represent shared variation, a dietary intervention, or another defined target. Different score-construction methods answer different questions.
- Hazard ratio (HR): A comparison of event hazards during follow-up. Interpretation requires the exposure contrast, adjustment model, and confidence interval; it does not directly describe an absolute risk reduction.
1. What Problem Are Biomarkers Intended to Solve?
Habitual diet is difficult to measure
- Questions about chronic disease usually concern exposure over months or years. A brief record of recent intake may incompletely represent that exposure.
- Food frequency questionnaires, food records, and 24-hour recalls depend on reporting, food identification, portion estimation, and the information used to translate foods into